Strides Arcolab’s specialties arm inks pact with Malaysian Bio-XCell Ecosystem

29 Jun 2011 Evaluate

Stride Arcolab’s specialties subsidiary Agila Specialists (Malaysia) and Malaysian Bio-XCell, the investment arm of Malaysian Biotechnology Corporation, has exchanged agreement for the establishment of a customized facility to manufacture biopharmaceuticals and sterile injectables in the Bio-Xcell ecosystem in Johor, Malaysia.

The agreement was exchanged by Adam Levitt, CEO-Americas of Strides Arcolab and Raja Ridzwa Raja Abdul Aziz, CEO of Bio-XCell in the presence of Tan Myhyiddin Yassin, Deputy Price Minister of Malaysia during the Bio Intentional Convention 2011 in Washington DC.

The project will be built by Bio-Xcell to the design requirements of Strides and will be leased out to Strides on a long-term basis. The lease rentals are applicable from the date of commercialization which supports the biotech strategy of Strides where there is a long gestation period from development to commercialization.

Strides Arcolab is a global pharmaceuticals company headquartered in Banglore, India that develops and manufactures wide range of IP-led niche pharmaceuticals products with an emphasis on sterlite injectables.

Strides Pharma Scien Share Price

918.75 -19.65 (-2.09%)
26-Dec-2025 13:45 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1715.00
Dr. Reddys Lab 1267.40
Cipla 1506.70
Zydus Lifesciences 911.65
Lupin 2107.55
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×